Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | -0.19% |
|
+15.18% | +98.46% |
04/06 | LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License | CI |
15/05 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- Official Publications